HFA Premium Access

All-cause mortality in hypertrophic cardiomyopathy (HCM) compared to the general population in England and the US

Congress Presentation

About the speaker

Professor Maria Teresa Tome Esteban

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
6 presentations
1 follower

6 more presentations in this session

Betablockers or calcium channel blockers in hypertrophic cardiomyopathy

Speaker: Doctor G. Pinto (Milan, IT)


Myocardial extracellular space expansion and diastolic function is related to QRS-T angle in patients with hypertrophic cardiomyopathy

Speaker: Doctor H. Chung (Seoul, KR)


Septal microsphere embolization in hypertrophic obstructive cardiomyopathy: a quindecennial single-center experience

Speaker: Doctor E. Alyaydin (Zurich, CH)


No variant tranythyretin amyloidosis is found in a large non-red-flag selected cardiomyopathy population

Speaker: Doctor H. Takacs (Szeged, HU)


Long-term cardiovascular outcomes and events by New York Heart Association class in patients with obstructive hypertrophic cardiomyopathy in England

Speaker: Doctor B. Sandler (GB) Mr M. Hurst (London, GB)


Access the full session

Myocardial disease - hypertrophic cardiomyopathy 2

Speakers: Professor M. Tome Esteban, Doctor G. Pinto, Doctor H. Chung, Doctor E. Alyaydin, Doctor H. Takacs...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by